Logo

Genome Medical: Brandon Poe, Marco Barcella, Russell Glass

Mar 31, 2021

South San Francisco-based digital health firm Genome Medical has made appointments to its management team and board of directors.

Brandon Poe has become the company's CFO. Previously, he was VP of finance at Illumina, and before that, CFO of medical device firm Sotera Wireless. He holds an MBA from the University of Chicago Booth School of Business and a bachelor's degree from Bucknell University.

Marco Barcella has been appointed as Genome Medical's chief product officer. Most recently, he held strategic product positions at Tiatros and at IBM Watson Health. He holds an MBA from the NYU Stern School of Business and a master of science degree from the University of Virginia.

Russell Glass has joined the firm as an independent director. He is the CEO of on-demand mental health company Ginger. Prior to that, he was the founder and CEO of Bizo, a B2B marketing and data firm that was sold to LinkedIn in 2014, which he then joined.

Breaking News
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.